These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25474433)

  • 1. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?
    Jianyong L; Lunan Y; Wentao W; Yong Z; Bo L; Tianfu W; Minqing X; Jiaying Y
    Medicine (Baltimore); 2014 Nov; 93(26):e180. PubMed ID: 25474433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
    Yang B; Zheng B; Yang M; Zeng Z; Yang F; Pu J; Li C; Liao Z
    Hepatol Int; 2018 Sep; 12(5):417-428. PubMed ID: 30073454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Wang D; Su C; Li H; Guo X
    Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A.
    Jin YJ; Lee JW; Choi YJ; Chung HJ; Kim YS; Lee KY; Ahn SI; Shin WY; Cho SG; Jeon YS
    J Gastrointest Surg; 2014 Mar; 18(3):555-61. PubMed ID: 24420729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
    Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
    AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?
    Lin CT; Hsu KF; Chen TW; Yu JC; Chan DC; Yu CY; Hsieh TY; Fan HL; Kuo SM; Chung KP; Hsieh CB
    World J Surg; 2010 Sep; 34(9):2155-61. PubMed ID: 20407768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
    Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J
    Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
    Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
    Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.
    Zhong JH; Xiang BD; Gong WF; Ke Y; Mo QG; Ma L; Liu X; Li LQ
    PLoS One; 2013; 8(7):e68193. PubMed ID: 23874536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
    Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
    Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.
    Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y
    Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis.
    Liang L; Xing H; Zhang H; Zhong J; Li C; Lau WY; Wu M; Shen F; Yang T
    HPB (Oxford); 2018 Feb; 20(2):110-119. PubMed ID: 29174493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
    Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
    Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
    Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
    Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
    Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.